NeuroOne Medical Technologies Corporation (NMTC)
USD 0.86
(0.0%)
USD 0.86
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.13 Million USD | 35.43% |
| 2022 | -7.95 Million USD | -20.83% |
| 2021 | -6.58 Million USD | -142.39% |
| 2020 | -2.71 Million USD | -942.0% |
| 2019 | -260.74 Thousand USD | -115.67% |
| 2018 | 1.66 Million USD | -30.54% |
| 2017 | 2.39 Million USD | 1069.51% |
| 2016 | -247.02 Thousand USD | -1698.11% |
| 2015 | 15.45 Thousand USD | 7640.0% |
| 2014 | -205.00 USD | -100.75% |
| 2013 | 27.47 Thousand USD | 72.99% |
| 2012 | 15.88 Thousand USD | 214.66% |
| 2011 | -13.85 Thousand USD | -51.73% |
| 2010 | -9129.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.31 Million USD | 8.49% |
| 2024 Q3 | -1.32 Million USD | 42.5% |
| 2024 Q1 | -2.52 Million USD | 50.81% |
| 2023 Q3 | -2.86 Million USD | 14.57% |
| 2023 Q4 | -5.13 Million USD | -79.09% |
| 2023 FY | -5.13 Million USD | 35.43% |
| 2023 Q1 | -4.39 Million USD | 44.77% |
| 2023 Q2 | -3.35 Million USD | 23.59% |
| 2022 FY | -7.95 Million USD | -20.83% |
| 2022 Q1 | -15.89 Million USD | -141.37% |
| 2022 Q4 | -7.95 Million USD | 20.0% |
| 2022 Q3 | -9.94 Million USD | 21.11% |
| 2022 Q2 | -12.6 Million USD | 20.68% |
| 2021 Q3 | -8.72 Million USD | 20.64% |
| 2021 Q1 | -6.83 Million USD | -151.41% |
| 2021 Q2 | -10.98 Million USD | -60.89% |
| 2021 FY | -6.58 Million USD | -142.39% |
| 2021 Q4 | -6.58 Million USD | 24.49% |
| 2020 Q4 | -2.71 Million USD | -184.13% |
| 2020 Q1 | 3.48 Million USD | 1436.8% |
| 2020 Q2 | 4.51 Million USD | 29.47% |
| 2020 FY | -2.71 Million USD | -942.0% |
| 2020 Q3 | 3.22 Million USD | -28.44% |
| 2019 Q4 | -260.74 Thousand USD | 79.09% |
| 2019 Q3 | -1.24 Million USD | 39.95% |
| 2019 Q1 | 1.83 Million USD | 10.32% |
| 2019 Q2 | -2.07 Million USD | -213.14% |
| 2019 FY | -260.74 Thousand USD | -115.67% |
| 2018 FY | 1.66 Million USD | -30.54% |
| 2018 Q4 | 1.66 Million USD | -51.65% |
| 2018 Q3 | 3.44 Million USD | 20.77% |
| 2018 Q2 | 2.84 Million USD | 18.96% |
| 2018 Q1 | 2.39 Million USD | 50.25% |
| 2017 Q1 | -247.02 Thousand USD | 0.0% |
| 2017 Q2 | 38.25 Thousand USD | 115.49% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q4 | 1.59 Million USD | 0.0% |
| 2017 FY | 2.39 Million USD | 1069.51% |
| 2016 Q1 | 15.45 Thousand USD | 68.97% |
| 2016 FY | -247.02 Thousand USD | -1698.11% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | -100.0% |
| 2016 Q2 | 15.81 Thousand USD | 2.34% |
| 2015 FY | 15.45 Thousand USD | 7640.0% |
| 2015 Q2 | -195.00 USD | 4.88% |
| 2015 Q4 | 9148.00 USD | 78.92% |
| 2015 Q3 | 5113.00 USD | 2722.05% |
| 2015 Q1 | -205.00 USD | -101.23% |
| 2014 Q2 | -500.00 USD | -101.82% |
| 2014 Q1 | 27.47 Thousand USD | 6.11% |
| 2014 FY | -205.00 USD | -100.75% |
| 2014 Q4 | 16.61 Thousand USD | 2543.97% |
| 2014 Q3 | -680.00 USD | -36.0% |
| 2013 Q4 | 25.89 Thousand USD | 9.42% |
| 2013 FY | 27.47 Thousand USD | 72.99% |
| 2013 Q2 | 15.86 Thousand USD | -0.09% |
| 2013 Q1 | 15.88 Thousand USD | 9.42% |
| 2013 Q3 | 23.66 Thousand USD | 49.13% |
| 2012 FY | 15.88 Thousand USD | 214.66% |
| 2012 Q3 | 9954.00 USD | 29.81% |
| 2012 Q4 | 14.51 Thousand USD | 45.82% |
| 2012 Q2 | 7668.00 USD | 155.36% |
| 2012 Q1 | -13.85 Thousand USD | -224.89% |
| 2011 Q1 | -9129.00 USD | 0.0% |
| 2011 FY | -13.85 Thousand USD | -51.73% |
| 2011 Q4 | 11.09 Thousand USD | -1.11% |
| 2011 Q3 | 11.21 Thousand USD | 0.0% |
| 2010 FY | -9129.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acutus Medical, Inc. | 12.27 Million USD | 141.845% |
| Cerus Corporation | 84.35 Million USD | 106.091% |
| OrthoPediatrics Corp. | -9.26 Million USD | 44.555% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 502.156% |
| Talis Biomedical Corporation | -57.06 Million USD | 90.996% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1559.686% |
| Inogen, Inc. | -103.56 Million USD | 95.039% |
| Spectral AI, Inc. | -3.5 Million USD | -46.761% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 89.302% |
| CVRx, Inc. | -59.95 Million USD | 91.43% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 358.958% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -0.255% |
| Orthofix Medical Inc. | 96.44 Million USD | 105.328% |
| Venus Concept Inc. | 74.3 Million USD | 106.915% |
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 118.972% |
| Bioventus Inc. | 372.51 Million USD | 101.379% |
| BrainsWay Ltd. | -10.32 Million USD | 50.212% |
| Envoy Medical, Inc. | -3.81 Million USD | -34.717% |
| electroCore, Inc. | -9.95 Million USD | 48.387% |
| IceCure Medical Ltd | -9.93 Million USD | 48.278% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -41.118% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 60.769% |
| MaxCyte, Inc. | -27.76 Million USD | 81.493% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -792.391% |
| PAVmed Inc | 29.08 Million USD | 117.665% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 69.667% |
| RxSight, Inc. | -6.68 Million USD | 23.082% |
| Sight Sciences, Inc. | -102.71 Million USD | 94.998% |
| SI-BONE, Inc. | 5.72 Million USD | 189.811% |
| TELA Bio, Inc. | -3.94 Million USD | -30.111% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 49.537% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 108.964% |
| LivaNova PLC | 62.53 Million USD | 108.217% |
| 908 Devices Inc. | -115.09 Million USD | 95.536% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.602% |
| Nemaura Medical Inc. | 9.92 Million USD | 151.769% |
| NeuroPace, Inc. | 54.33 Million USD | 109.456% |
| LENSAR, Inc. | -18.31 Million USD | 71.941% |
| Apyx Medical Corporation | -5.15 Million USD | 0.251% |
| Cutera, Inc. | 288.3 Million USD | 101.782% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 168.371% |
| BioSig Technologies, Inc. | 262 Thousand USD | 2061.104% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 88.277% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 44.145% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.366% |
| Axonics, Inc. | -77.19 Million USD | 93.344% |
| Outset Medical, Inc. | 67.67 Million USD | 107.592% |
| IRIDEX Corporation | -4.28 Million USD | -19.825% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 97.114% |
| IRadimed Corporation | -47.71 Million USD | 89.233% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -69.798% |
| INVO Bioscience, Inc. | 8.45 Million USD | 160.798% |
| Telesis Bio, Inc. | 32.63 Million USD | 115.744% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -105.349% |
| Varex Imaging Corporation | 316.9 Million USD | 101.621% |
| Quipt Home Medical Corp. | 81.73 Million USD | 106.286% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -84.691% |
| Pulmonx Corporation | -42.36 Million USD | 87.87% |
| Dynatronics Corporation | 6.2 Million USD | 182.819% |
| Modular Medical, Inc. | -8.04 Million USD | 36.109% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -19.574% |
| Semler Scientific, Inc. | -57.13 Million USD | 91.006% |
| InMode Ltd. | -135.39 Million USD | 96.205% |
| Bruker Corporation | 891.3 Million USD | 100.576% |
| Cytosorbents Corporation | 4.18 Million USD | 222.862% |
| DexCom, Inc. | 2.02 Billion USD | 100.253% |
| Align Technology, Inc. | -840.47 Million USD | 99.389% |
| Viveve Medical, Inc. | -13.81 Million USD | 62.802% |
| ZimVie Inc. | 450.41 Million USD | 101.141% |
| Movano Inc. | -5.86 Million USD | 12.409% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 96.179% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -792.391% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 358.958% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 101.44% |
| Profound Medical Corp. | -18.17 Million USD | 71.735% |
| Insulet Corporation | 798.1 Million USD | 100.644% |
| enVVeno Medical Corporation | -2.21 Million USD | -131.654% |
| Surmodics, Inc. | -12.01 Million USD | 57.232% |
| iCAD, Inc. | -21.2 Million USD | 75.774% |
| Nuwellis, Inc. | -2.81 Million USD | -82.267% |
| Biotricity, Inc. | 23.09 Million USD | 122.25% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 105.486% |
| Aethlon Medical, Inc. | -4.5 Million USD | -14.138% |
| InspireMD, Inc. | -8.04 Million USD | 36.133% |
| PAVmed Inc. | 29.08 Million USD | 117.665% |
| BIOLASE, Inc. | 11.34 Million USD | 145.293% |
| Beyond Air, Inc. | 6.22 Million USD | 182.487% |
| FONAR Corporation | -14.66 Million USD | 64.964% |
| AxoGen, Inc. | 32.26 Million USD | 115.924% |
| Vivani Medical, Inc. | 42 Thousand USD | 12333.555% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 51.791% |
| Inari Medical, Inc. | -7.16 Million USD | 28.249% |
| UFP Technologies, Inc. | 40.77 Million USD | 112.601% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 267.44% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -7.687% |
| Tenon Medical, Inc. | -1.25 Million USD | -309.41% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 32.447% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 56.918% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.232% |
| Sintx Technologies, Inc. | 905 Thousand USD | 667.745% |
| NanoVibronix, Inc. | -3.27 Million USD | -56.745% |
| Quanterix Corporation | -132.95 Million USD | 96.136% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -84.691% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 77.026% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.682% |
| TransMedics Group, Inc. | 121.13 Million USD | 104.242% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 80.374% |
| NeuroMetrix, Inc. | -1.49 Million USD | -244.591% |
| Hyperfine, Inc. | -75.61 Million USD | 93.205% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 103.376% |
| Biomerica, Inc. | -3.38 Million USD | -51.79% |
| Bone Biologics Corporation | -3.02 Million USD | -69.766% |
| AVITA Medical, Inc. | -26.23 Million USD | 80.413% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -179.486% |
| Silk Road Medical, Inc | 64.42 Million USD | 107.976% |